Enlivex Therapeutics Statistics

Total Valuation

TLV:ENLV has a market cap or net worth of ILS 78.38 million. The enterprise value is -6.24 million.

Market Cap	78.38M
Enterprise Value	-6.24M

Important Dates

The next estimated earnings date is Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+5.43%
Shares Change (QoQ)	+8.87%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	16.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	0.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.09
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.12

Financial Position

The company has a current ratio of 9.71, with a Debt / Equity ratio of 0.03.

Current Ratio	9.71
Quick Ratio	9.28
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-0.05
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -57.93% and return on invested capital (ROIC) is -28.57%.

Return on Equity (ROE)	-57.93%
Return on Assets (ROA)	-26.30%
Return on Invested Capital (ROIC)	-28.57%
Return on Capital Employed (ROCE)	-59.79%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -68.87% in the last 52 weeks. The beta is 0.99, so TLV:ENLV's price volatility has been similar to the market average.

Beta (5Y)	0.99
52-Week Price Change	-68.87%
50-Day Moving Average	412.63
200-Day Moving Average	474.20
Relative Strength Index (RSI)	40.47
Average Volume (20 Days)	37,375

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.61

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-60.02M
Pretax Income	-70.38M
Net Income	-70.38M
EBITDA	-57.38M
EBIT	-60.02M
Earnings Per Share (EPS)	-3.60

Full Income Statement

Balance Sheet

The company has 91.09 million in cash and 2.84 million in debt, giving a net cash position of 88.25 million.

Cash & Cash Equivalents	91.09M
Total Debt	2.84M
Net Cash	88.25M
Net Cash Per Share	n/a
Equity (Book Value)	98.83M
Book Value Per Share	4.49
Working Capital	90.40M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -52.79 million and capital expenditures -278,798, giving a free cash flow of -53.07 million.

Operating Cash Flow	-52.79M
Capital Expenditures	-278,798
Free Cash Flow	-53.07M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TLV:ENLV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.43%
Shareholder Yield	-5.43%
Earnings Yield	-89.79%
FCF Yield	-67.70%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a